Tushar Patni
YOU?
Author Swipe
View article: Preclinical evaluation of antisense oligonucleotide therapy in a mouse model of <i>HNRNPH2</i> -related neurodevelopmental disorder
Preclinical evaluation of antisense oligonucleotide therapy in a mouse model of <i>HNRNPH2</i> -related neurodevelopmental disorder Open
Summary Mutations in HNRNPH2 cause an X-linked disorder characterized by developmental delay, intellectual disability, motor and gait disturbances, and seizures. Murine models that reproduce key clinical features of HNRNPH2-related neurode…
View article: 37 | PATTERNS OF FATIGUE IN HIGH‐RISK PEDIATRIC HODGKIN LYMPHOMA (HL) TREATED WITH PEDIATRIC HODGKIN CONSORTIUM (PHC) BRENTUXIMAB VEDOTIN‐CONTAINING EUROPEAN‐DERIVED REGIMENS
37 | PATTERNS OF FATIGUE IN HIGH‐RISK PEDIATRIC HODGKIN LYMPHOMA (HL) TREATED WITH PEDIATRIC HODGKIN CONSORTIUM (PHC) BRENTUXIMAB VEDOTIN‐CONTAINING EUROPEAN‐DERIVED REGIMENS Open
View article: Correction: Contrast enhanced ultrasound of liver lesions in patients treated for childhood malignancies
Correction: Contrast enhanced ultrasound of liver lesions in patients treated for childhood malignancies Open
View article: Contrast enhanced ultrasound of liver lesions in patients treated for childhood malignancies
Contrast enhanced ultrasound of liver lesions in patients treated for childhood malignancies Open
View article: Hydroxyurea maintains working memory function in pediatric sickle cell disease
Hydroxyurea maintains working memory function in pediatric sickle cell disease Open
Sickle cell disease (SCD) decreases the oxygen-carrying capacity of red blood cells. Children with SCD have reduced/restricted cerebral blood flow, resulting in neurocognitive deficits. Hydroxyurea is the standard treatment for SCD; howeve…
View article: gsMAMS: an R package for Designing Multi-ArmMulti-Stage Clinical Trials
gsMAMS: an R package for Designing Multi-ArmMulti-Stage Clinical Trials Open
In the field of clinical trial design, a multi-arm trial allows simultaneous comparison of multiple experimental treatments with a common control and provides a substantial efficiency advantage compared to conventional randomized controlle…
View article: A murine model of hnRNPH2-related neurodevelopmental disorder reveals a mechanism for genetic compensation by Hnrnph1
A murine model of hnRNPH2-related neurodevelopmental disorder reveals a mechanism for genetic compensation by Hnrnph1 Open
View article: COVID-19 in Pediatric Patients With Acute Lymphoblastic Leukemia or Lymphoma
COVID-19 in Pediatric Patients With Acute Lymphoblastic Leukemia or Lymphoma Open
Importance COVID-19 in pediatric patients with acute lymphoblastic leukemia or lymphoma (ALL/LLy) has not been described in detail and may affect chemotherapy administration and long-term outcomes. Objective To describe the clinical presen…
View article: [11C]-methionine positron emission tomography in the evaluation of pediatric low-grade gliomas
[11C]-methionine positron emission tomography in the evaluation of pediatric low-grade gliomas Open
Background [11C]-Methionine positron emission tomography (PET; [11C]-MET-PET) is principally used for the evaluation of brain tumors in adults. Although amino acid PET tracers are more commonly used in the evaluation of pediatric brain tum…
View article: Hydroxyurea maintains working memory function in pediatric sickle cell disease
Hydroxyurea maintains working memory function in pediatric sickle cell disease Open
Pediatric patients with sickle cell disease (SCD) have decreased oxygen-carrying capacity in the blood and reduced or restricted cerebral blood flow resulting in neurocognitive deficits and cerebral infarcts. The standard treatment for chi…
View article: A murine model of hnRNPH2-related neurodevelopmental disorder reveals a mechanism for genetic compensation by Hnrnph1
A murine model of hnRNPH2-related neurodevelopmental disorder reveals a mechanism for genetic compensation by Hnrnph1 Open
Mutations in HNRNPH2 cause an X-linked neurodevelopmental disorder with features that include developmental delay, motor function deficits, and seizures. More than 90% of patients with hnRNPH2 have a missense mutation within or adjacent to…
View article: Factors for poor oral health in long-term childhood cancer survivors
Factors for poor oral health in long-term childhood cancer survivors Open
The first dataset "survivors+controls" contains data which was used in the analysis for table2, table4, table5 and table6. The second dataset "survivors" contains data which was used in the analysis for table3, and table7.
View article: Factors for poor oral health in long-term childhood cancer survivors
Factors for poor oral health in long-term childhood cancer survivors Open
The first dataset "survivors+controls" contains data which was used in the analysis for table2, table4, table5 and table6. The second dataset "survivors" contains data which was used in the analysis for table3, and table7.
View article: Factors for poor oral health in long-term childhood cancer survivors
Factors for poor oral health in long-term childhood cancer survivors Open
View article: A Phase IV Trial of Proton Therapy in Children: The First Report from the SJPROTON1 Study
A Phase IV Trial of Proton Therapy in Children: The First Report from the SJPROTON1 Study Open
Importance Early reports suggest adverse events following proton therapy (PT) for childhood cancer are more prevalent given the increased number of PT centers and use in clinical trials. Objective To assess treatment-failure and toxicity e…
View article: Inpatient Teleneurology Follow-up Has Comparable Outcomes to In-Person Neurology Follow-up
Inpatient Teleneurology Follow-up Has Comparable Outcomes to In-Person Neurology Follow-up Open
Teleneurology follow-up resulted in comparable outcomes to in-person neurology follow-up, with few transfers after admission. For select neurology and ischemic stroke patients, teleneurology follow-up provides an alternative to transfer fo…
View article: Low‐dose ketamine infusions reduce opioid use in pediatric and young adult oncology patients
Low‐dose ketamine infusions reduce opioid use in pediatric and young adult oncology patients Open
Background Ketamine is an NMDA‐receptor antagonist with analgesic and opioid‐sparing properties. Although well studied in adults, more robust evidence supporting ketamine's use for pediatric pain management is needed. This retrospective st…
View article: A murine model of hnRNPH2-related neurodevelopmental disorder recapitulates clinical features of human disease and reveals a mechanism for genetic compensation of<i>HNRNPH2</i>
A murine model of hnRNPH2-related neurodevelopmental disorder recapitulates clinical features of human disease and reveals a mechanism for genetic compensation of<i>HNRNPH2</i> Open
Mutations in HNRNPH2 cause an X-linked neurodevelopmental disorder with a phenotypic spectrum that includes developmental delay, intellectual disability, language impairment, motor function deficits, and seizures. More than 90% of patients…
View article: A Phase IV Trial of Proton Therapy in Children: The First Report from SJPROTON1
A Phase IV Trial of Proton Therapy in Children: The First Report from SJPROTON1 Open